The Optimal First‐Line Therapy of Helicobacter pylori Infection in Year 2012
CH Kuo, FC Kuo, HM Hu, CJ Liu… - Gastroenterology …, 2012 - Wiley Online Library
This paper reviews the literature about first‐line therapies for H. pylori infection in recent
years. First‐line therapies are facing a challenge because of increasing treatment failure …
years. First‐line therapies are facing a challenge because of increasing treatment failure …
Treatment of Helicobacter pylori infection: A clinical practice update.
Helicobacter pylori infection still represents a major health issue, especially in developing
countries, with an estimate of 4 billion of infected subjects in 2015. The increase of antibiotic …
countries, with an estimate of 4 billion of infected subjects in 2015. The increase of antibiotic …
[HTML][HTML] Helicobacter pylori: management in 2013
YO Alahdab, C Kalayci - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a prevalent, worldwide, chronic infection. Choice of
treatment can be modified according to antibiotic-resistance rates of H. pylori. The ideal …
treatment can be modified according to antibiotic-resistance rates of H. pylori. The ideal …
Treatment of Helicobacter pylori Infection 2014
This review summarizes important studies regarding H. pylori therapy published from April
2013 to April 2014. The main themes that emerge are assessing the efficacy of standard …
2013 to April 2014. The main themes that emerge are assessing the efficacy of standard …
[HTML][HTML] Second and third line treatment options for Helicobacter pylori eradication
M Song, TL Ang - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori is a highly successful bacterium with a high global prevalence and the
infection carries significant disease burden. It is also becoming increasingly difficult to …
infection carries significant disease burden. It is also becoming increasingly difficult to …
Treatment of Helicobacter pylori
K Wolle, P Malfertheiner - Best Practice & Research Clinical …, 2007 - Elsevier
Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …
An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection
S Georgopoulos, V Papastergiou - Expert Opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Eradication of Helicobacter pylori (H. pylori) becomes more
challenging due to increasing antimicrobial resistance. Consequently, the performance of …
challenging due to increasing antimicrobial resistance. Consequently, the performance of …
Treatment of Helicobacter pylori infection: A clinical practice update
RM Zagari, S Rabitti, LH Eusebi… - European journal of …, 2018 - Wiley Online Library
Background Helicobacter pylori infection is still frequent in the community and all infected
subjects should be offered an eradication therapy. Nowadays physicians have to face the …
subjects should be offered an eradication therapy. Nowadays physicians have to face the …
Optimal First‐Line Treatment for Helicobacter pylori Infection: Recent Strategies
JY Lee, KS Park - Gastroenterology Research and Practice, 2016 - Wiley Online Library
A new treatment strategy is needed, as the efficacy of triple therapy containing clarithromycin—
the current standard treatment for Helicobacter pylori infection—is declining. Increasing …
the current standard treatment for Helicobacter pylori infection—is declining. Increasing …
[HTML][HTML] Treatment of Helicobacter pylori infection: Past, present and future
V Papastergiou, SD Georgopoulos… - World journal of …, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a major human pathogen associated with significant
morbidity and mortality. However, after decades of efforts, treatment of H. pylori remains a …
morbidity and mortality. However, after decades of efforts, treatment of H. pylori remains a …